Dose of Cilnidipine
The recommended starting dose of cilnidipine is 10 mg once daily, which can be titrated up to 20 mg once daily based on blood pressure response.
Dosing Regimen
Standard Adult Dosing
- Starting dose: 10 mg once daily 1, 2
- Titration: Adjust to 5-20 mg/day to achieve target blood pressure 2
- Maximum dose: 20 mg once daily 3
- Timing: Can be administered either in the morning or at bedtime with equivalent efficacy 4
The evidence demonstrates that cilnidipine 10 mg once daily significantly reduces 24-hour blood pressure by approximately 6.5/5.0 mmHg (systolic/diastolic) without causing reflex tachycardia or increased sympathetic nervous activity 1. When 10 mg is insufficient, titration to 20 mg provides additional blood pressure reduction while maintaining tolerability 2, 3.
Elderly Patients
While the provided guidelines 5 recommend starting with low-dose calcium channel blockers in elderly patients and individualizing based on frailty, specific cilnidipine dosing data for elderly patients is not available in the evidence provided. Following general principles for dihydropyridine calcium channel blockers, initiate at 10 mg daily with careful monitoring, particularly for orthostatic hypotension.
Renal Impairment
No specific dose adjustment is documented for moderate renal impairment. However, cilnidipine demonstrates renoprotective effects in hypertensive patients with chronic kidney disease, significantly reducing proteinuria when used at standard doses (10-20 mg daily) 3, 6. The drug can be safely used in CKD patients at standard doses while providing additional renal benefits beyond blood pressure reduction.
Hepatic Impairment
No specific cilnidipine dosing recommendations for hepatic impairment are provided in the available evidence. The FDA drug labels 7 discuss cyclobenzaprine (not cilnidipine), so cannot be used for guidance. In the absence of specific data, exercise caution and consider starting at the lower end of the dosing range (5-10 mg daily) with careful monitoring.
Clinical Considerations
Key advantages of cilnidipine's dual L/N-type calcium channel blockade:
- No reflex tachycardia (unlike pure L-type blockers like amlodipine) 1, 4, 8
- Reduced pedal edema compared to other dihydropyridines 8
- Renoprotective effects with reduction in proteinuria 3, 6
- Antioxidant properties that may provide additional cardiovascular protection 3
Monitoring: Assess blood pressure response after 6-12 weeks of treatment. Target blood pressure should be achieved within 3 months per current hypertension guidelines 5, 9.
Common pitfall: Do not assume cilnidipine requires the same precautions as traditional L-type calcium channel blockers regarding heart rate increases—its N-type blockade prevents sympathetic activation and reflex tachycardia 1, 4.